SCHEMBL9700316

SCHEMBL9700316

CSc1ccc2ccc(C(=O)CC(C)=O)cc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.47
KDM4E B2RXH2 1/20 0.47
HPGD P15428 1/20 0.47
HAO1 Q9UJM8 1/20 0.45
PLK1 P53350 1/20 0.42
CYP2A6 P11509 1/20 0.41
NQO2 P16083 1/20 0.41
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
PTPN1 P18031 1/20 0.40
AKR1C3 P42330 3/20 0.40
AKR1C2 P52895 3/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TAS1R3 Q7RTX0 1/20 0.38
TAS1R1 Q7RTX1 1/20 0.38
ADORA3 P0DMS8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4707187 0.83 HAO1 (0.62) SMN1; SMN2KDM4EHPGDHAO1PLK1
SCHEMBL9699266 0.80 CYP2A6 (0.66) SMN1; SMN2KDM4EHPGDCYP2A6PTPN1
SCHEMBL2774094 0.80 SMN1; SMN2 (0.72) SMN1; SMN2KDM4EHPGDPTPN1NPC1
SCHEMBL10414901 0.78 SMN1; SMN2 (0.49) SMN1; SMN2KDM4EHPGDHAO1PLK1
SCHEMBL3556153 0.78 KDM4E (0.50) SMN1; SMN2KDM4EHPGDPLK1CYP2A6
SCHEMBL10415427 0.77 PTPN1 (0.64) SMN1; SMN2KDM4EHPGDHAO1PLK1
SCHEMBL9701379 0.76 CYP1A2 (0.61) SMN1; SMN2KDM4EHPGDCYP2A6AKR1C3
SCHEMBL9701342 0.75 GAA (0.46) SMN1; SMN2KDM4EHPGDCYP2A6NQO2
SCHEMBL28482006 0.75 CYP2A6 (0.58) SMN1; SMN2KDM4EHPGDCYP2A6PTPN1
SCHEMBL9700437 0.74 SMN1; SMN2 (0.44) SMN1; SMN2KDM4EHPGDCYP2A6PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5112820-A Vision defects STERLING DRUG INC. (US) 1992-05-12 US disclosed
US-5109135-A 2- or 3-aminomethyl-4-amino-3,4-dihydro-2H-1,4-benzoxazine intermediates STERLING DRUG INC. (US) 1992-04-28 US disclosed
US-5066803-A Chemical intermediates for analgesics STERLING DRUG INC. (US) 1991-11-19 US disclosed
WO-1990007505-A1 2- AND 3-AMINOMETHYL-6-ARYLCARBONYL-2,3-DIHYDROPYRROLO[1,2,3-de]-1,4-BENZOXAZINES STERLING DRUG INC. (US) 1990-07-12 WO disclosed